Federico Del Vento1, Jonathan Poels1, Maxime Vermeulen1, Bernard Ucakar2, Maria Grazia Giudice1,3, Marc Kanbar1, Anne des Rieux2, Christine Wyns1,3. 1. Gynecology-Andrology Unit, Institute of Experimental and Clinical Research, Medical School, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium. 2. Advanced Drug Delivery and Biomaterials Unit, Louvain Drug Research Institute, Catholic University of Louvain, UCLouvain, 1200 Brussels, Belgium. 3. Department of Gynecology-Andrology, Saint-Luc University Hospital, 1200 Brussels, Belgium.
Abstract
Avascular transplantation of frozen-thawed testicular tissue fragments represents a potential future technique for fertility restoration in boys with cancer. A significant loss of spermatogonia was observed in xeno-transplants of human tissue most likely due to the hypoxic period before revascularization. To reduce the effect of hypoxia-reoxygenation injuries, several options have already been explored, like encapsulation in alginate hydrogel and supplementation with nanoparticles delivering a necrosis inhibitor (NECINH) or VEGF. While these approaches improved short-term (5 days) vascular surfaces in grafts, neovessels were not maintained up to 21 days; i.e., the time needed for achieving vessel stabilization. To better support tissue grafts, nanoparticles loaded with VEGF, PDGF and NECINH were developed. Testicular tissue fragments from 4-5-week-old mice were encapsulated in calcium-alginate hydrogels, either non-supplemented (control) or supplemented with drug-loaded nanoparticles (VEGF-nanoparticles; VEGF-nanoparticles + PDGF-nanoparticles; NECINH-nanoparticles; VEGF-nanoparticles + NECINH-nanoparticles; and VEGF-nanoparticles + PDGF-nanoparticles + NECINH-nanoparticles) before auto-transplantation. Grafts were recovered after 5 or 21 days for analyses of tissue integrity (hematoxylin-eosin staining), spermatogonial survival (immuno-histo-chemistry for promyelocytic leukemia zinc finger) and vascularization (immuno-histo-chemistry for α-smooth muscle actin and CD-31). Our results showed that a combination of VEGF and PDGF nanoparticles increased vascular maturity and induced a faster maturation of vascular structures in grafts.
Avascular transplantation of frozen-thawed testicular tissue fragments represents a potential future technique for fertility reston class="Species">rationpan> inpan> pan> class="Species">boys with cancer. A significant loss of spermatogonia was observed in xeno-transplants of human tissue most likely due to thehypoxic period before revascularization. To reduce the effect of hypoxia-reoxygenation injuries, several options have already been explored, like encapsulation in alginate hydrogel and supplementation with nanoparticles delivering a necrosis inhibitor (NECINH) or VEGF. While these approaches improved short-term (5 days) vascular surfaces in grafts, neovessels were not maintained up to 21 days; i.e., the time needed for achieving vessel stabilization. To better support tissue grafts, nanoparticles loaded with VEGF, PDGF and NECINH were developed. Testicular tissue fragments from 4-5-week-old mice were encapsulated in calcium-alginate hydrogels, either non-supplemented (control) or supplemented with drug-loaded nanoparticles (VEGF-nanoparticles; VEGF-nanoparticles + PDGF-nanoparticles; NECINH-nanoparticles; VEGF-nanoparticles + NECINH-nanoparticles; and VEGF-nanoparticles + PDGF-nanoparticles + NECINH-nanoparticles) before auto-transplantation. Grafts were recovered after 5 or 21 days for analyses of tissue integrity (hematoxylin-eosin staining), spermatogonial survival (immuno-histo-chemistry for promyelocytic leukemia zinc finger) and vascularization (immuno-histo-chemistry for α-smooth muscle actin and CD-31). Our results showed that a combination of VEGF and PDGF nanoparticles increased vascular maturity and induced a faster maturation of vascular structures in grafts.
Authors: Christine Wyns; Anne Van Langendonckt; François-Xavier Wese; Jacques Donnez; Mara Curaba Journal: Hum Reprod Date: 2008-07-28 Impact factor: 6.918
Authors: Anne-Sophie Van Eyck; Bénédicte Francine Jordan; Bernard Gallez; Jean-François Heilier; Anne Van Langendonckt; Jacques Donnez Journal: Fertil Steril Date: 2008-08-09 Impact factor: 7.329
Authors: Jonathan Poels; Gaël Abou-Ghannam; Sophie Herman; Anne Van Langendonckt; François-Xavier Wese; Christine Wyns Journal: Front Surg Date: 2014-12-02
Authors: E Goossens; K Jahnukainen; R T Mitchell; Amm van Pelt; G Pennings; N Rives; J Poels; C Wyns; S Lane; K A Rodriguez-Wallberg; A Rives; H Valli-Pulaski; S Steimer; S Kliesch; A Braye; M M Andres; J Medrano; L Ramos; S G Kristensen; C Y Andersen; R Bjarnason; K E Orwig; N Neuhaus; J B Stukenborg Journal: Hum Reprod Open Date: 2020-06-06